Current genetic defects in common variable immunodeficiency patients on the geography between Europe and Asia: a single-center experience.

Common variable immunodeficiency Targeted next-generation sequencing Whole-exome sequencing

Journal

Immunologic research
ISSN: 1559-0755
Titre abrégé: Immunol Res
Pays: United States
ID NLM: 8611087

Informations de publication

Date de publication:
16 Oct 2023
Historique:
received: 12 08 2023
accepted: 01 10 2023
medline: 16 10 2023
pubmed: 16 10 2023
entrez: 15 10 2023
Statut: aheadofprint

Résumé

Identification of the causes of monogenetic common variable immunodeficiency (CVID) patients has rapidly increased in the last years by means of worldwide availability of appropriate genetic diagnostic methods. However, up to date, very limited numbers of reports demonstrating the role of geography, ethnicity, and consanguinity have been published. Here, we reported the first study of Turkish CVID patients and compared them with the results of three countries from America, Europe, and Asia. A total of 100 children diagnosed as CVID according to the criteria of European Society for Immunodeficiencies were enrolled, and they were genetically analyzed by using targeted next-generation sequencing and whole-exome sequencing. The median age of our patients was 5.8 years (range, 3.0-16.0 years) at clinical diagnosis and 9.0 years (range, 4.8-21.0 years) at the time of genetic diagnosis. The consanguinity rate was 24%. Disease-causing pathogenic variants were defined in 40% of patients in a total of 17 different genes. Sixteen of 40 identified pathogenic variants were novel (40%). We determined 18 surface molecular defects, 10 cytosolic defects, 9 nuclear defects, and 3 others. In our cohort, the most common gene was TACI (15/40 in pathogenic variant identified cases and 15/100 in all cases) followed by the others such as PLCү2, LRBA, TCF3, and STAT1. In contrast to our expectations, our results were more similar to American and European population rather than Asians, although we also have high consanguinity rates and live on the geography between Europe and Asia. Genetic investigation is a great challenge, because of the complexity and heterogeneity of the disease, and each country has to know their own current genetic landscape in CVID for a better and successful management of the patients.

Identifiants

pubmed: 37840117
doi: 10.1007/s12026-023-09426-9
pii: 10.1007/s12026-023-09426-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Jeffrey Modell Foundation
ID : No number

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Bogaert DJ, Dullaers M, Lambrecht BN, Vermaelen KY, De Baere E, Haerynck F. Genes associated with common variable immunodeficiency: one diagnosis to rule them all. J Med Genet. 2016;53:575–90.
doi: 10.1136/jmedgenet-2015-103690 pubmed: 27250108
Li J, Wei Z, Li YR, Maggadottir SM, Chang X, Desai A, Hakonarson H. Understanding the genetic and epigenetic basis of common variable immunodeficiency disorder through omics approaches. Biochim Biophys Acta. 2016;1860:2656–63.
doi: 10.1016/j.bbagen.2016.06.014 pubmed: 27316315
Li R, Zheng Y, Li Y, Zhang R, Wang F, Yang D, Ma Y, Mu X, Cao Z, Gao Z. Common variable immunodeficiency with genetic defects identified by whole exome sequencing. Biomed Res Int. 2018;2018:3724630. https://doi.org/10.1155/2018/3724630 .
doi: 10.1155/2018/3724630 pubmed: 30363934 pmcid: 6186323
Yazdani R, Habibi S, Sharifi L, Azizi G, Abolhassani H, Olbrich P, Aghamohammadi A. Common variable immunodeficiency: epidemiology, pathogenesis, clinical manifestations, diagnosis, classification and management. J Investig Allergol Clin Immunol. 2020;30:14–34.
doi: 10.18176/jiaci.0388 pubmed: 30741636
Abolhassani H, Hammarstrom L, Cunningha-Rundles C. Current genetic landscape in common variable immune deficiency. Blood. 2020;135:656–67.
doi: 10.1182/blood.2019000929 pubmed: 31942606 pmcid: 7046605
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
doi: 10.1038/gim.2015.30 pubmed: 25741868 pmcid: 4544753
Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010;6: e1001025.
doi: 10.1371/journal.pcbi.1001025 pubmed: 21152010 pmcid: 2996323
Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;7:20–30.
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.
doi: 10.1038/nprot.2009.86 pubmed: 19561590
Karaca NE, Severcan EU, Guven B, Azarsiz E, Aksu G, Kutukculer N. TNFRSF13B/TACI alterations in turkish patients with common variable immunodeficiency and IgA deficiency. Avicenna J Med Biotechnol. 2018;10:192–5.
pubmed: 30090215 pmcid: 6064010
Edeer Karaca N, Özek G, Ataseven E, Tökmeci N, Şenol HD, Kıran E. Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation in IL-21R gene and successful treatment with hematopoietic stem cell transplantation. Pediatr Hematol Oncol. 2021;38:745–52.
doi: 10.1080/08880018.2021.1924326 pubmed: 33966600
Kutukculer N, Topyildiz E, Berdeli A, Guven Bilgin B, Aykut A, Durmaz A, Cogulu O, et al. Four diseases, PLAID, APLAID, FCAS3 and CVID and one gene (PHOSPHOLIPASE C, GAMMA-2; PLCG2): striking clinical phenotypic overlap and difference. Clin Case Rep. 2021;9:2023–31.
doi: 10.1002/ccr3.3934 pubmed: 33936634 pmcid: 8077279
Eren Akarcan S, Edeer Karaca N, Aksu G, Aykut A, Yilmaz Karapinar D, Cetin F, et al. Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome. JMM Case Rep. 2018;5:e005167. https://doi.org/10.1099/jmmcr.0.005167 .
doi: 10.1099/jmmcr.0.005167 pubmed: 30479781 pmcid: 6249428
Jamee M, Azizi G, Baris S, Karakoc-Aydiner E, Ozen A, Kiliç SŞ, et al. Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry. J Clin Immunol. 2022;244:109131. https://doi.org/10.1016/j.clim.2022.109131 .
doi: 10.1016/j.clim.2022.109131
Eren Akarcan S, Ulusoy Severcan E, Edeer Karaca N, Isik E, Aksu G, Migaud M, et al. Gain-of-function mutations in STAT1: a recently defined cause for chronic mucocutaneous candidiasis disease mimicking combined immunodeficiencies. Case Rep in Immunol. 2017;2846928. https://doi.org/10.1155/2017/2846928 .
Edeer Karaca N, Aykut A, Parıltay E, Aksu G, Cogulu Ö, Kutukculer N. A novel TTC37 mutation causing clinical symptoms of trichohepatoenteric syndrome such as pyoderma gangrenosum and immunodeficiency without severe diarrhea. J Investig Allergol Clin Immunol. 2019;29:396–8.
doi: 10.18176/jiaci.0418
Driessen GJ, IJspeert H, Wentink M, Yntema HG, van Hagen PM, van Strien A, et al. Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency. J Allergy Clin Immunol. 2016;138:1744–7.
doi: 10.1016/j.jaci.2016.07.010 pubmed: 27531073
Topyıldız E, Karaca NE, Bas I, Aykut A, Durmaz A, Bilgin RBG, Aksu G, Karapınar DY, Kutukculer N. A novel homozygous TRNT1 mutation in a child with an early diagnosis of common variable immunodeficiency leading to mild hypogammaglobulinemia and hemolytic anemia. J Pediatr Hematol Oncol. 2021;43:e780–4.
doi: 10.1097/MPH.0000000000002101 pubmed: 33843817
Kutukculer N, Seeholzer T, O’Neill TJ, Graß C, Aykut A, Karaca NE, Durmaz A, Cogulu O, Aksu G, Gehring T, Gewies A, Krappmann D. Human immune disorder associated with homozygous hypomorphic mutation affecting MALT1B splice variant. J Allergy Clin Immunol. 2021;147:775–8.
doi: 10.1016/j.jaci.2020.07.034 pubmed: 32858082
Kutukculer N, Gulez N, Karaca NE, Aksu G, Berdeli A. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFRSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms, in Turkish patients with common variable immunodeficiency. J Clin Immunol. 2012;32:1165–79.
doi: 10.1007/s10875-012-9717-9 pubmed: 22699762
Karaca NE, Severcan EU, Bilgin BG, Azarsiz E, Akarcan S, Gunaydın NC, et al. Familial inheritance and screening of first-degree relatives in common variable immunodeficiency and immunoglobulin A deficiency patients. Int J Immunopathol Pharmacol. 2018;32:2058738418779458. https://doi.org/10.1177/2058738418779458 .
doi: 10.1177/2058738418779458 pubmed: 29978731 pmcid: 6073834
Bisgin A, Sonmezler O, Boga I, Yilmaz M. The impact of rare and low-frequency genetic variants in common variable immunodeficiency (CVID). Sci Rep. 2021;11:8308. https://doi.org/10.1038/s41598-021-87898-1 .
doi: 10.1038/s41598-021-87898-1 pubmed: 33859323 pmcid: 8050305
Shi C, Wang F, Tong A, Zhang XQ, Song HM, Liu ZY, Lyu W, Liu YH, Xia WB. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: a case report and review of literature. Medicine (Baltimore). 2016;95(40):e5081. https://doi.org/10.1097/MD.0000000000005081 .
doi: 10.1097/MD.0000000000005081 pubmed: 27749582 pmcid: 5059085
Luo MZ, Xu T, Hue XH, Wang YP, Wu PL, Chen XM, Tang XM, Zao XD, Zhang ZY. De novo NFKB2 gene mutation associated with common variable immunodeficiency. Zhonghua Er Ke Za Zhi. 2018;56:628–32.
pubmed: 30078247
Lee JJ, Özcan E, Rauter I, Geha RS. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2008;8:520–6.
doi: 10.1097/ACI.0b013e3283141200 pubmed: 18978466
Kaskas I, Tsinti G, Kalala F, Farmaki E, Kourakli A, Kapousouzi A, et al. TACI mutations in antibody deficiencies. A nationwide study in Greece. Medicina. 2021;57:827–35.
doi: 10.3390/medicina57080827
Firtina S, Ng YY, Ng OH, Kiykim A, Ozek EY, Kara M, et al. Primary antibody deficiencies in Turkey: molecular and clinical aspects. Immunol Res. 2022;70:44–55.
doi: 10.1007/s12026-021-09242-z pubmed: 34618307
Maffucci P, Filion CA, Boisson B, Itan Y, Shang L, Casanova JL, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220–6.
doi: 10.3389/fimmu.2016.00220 pubmed: 27379089 pmcid: 4903998
Kedar P, Dongerdiye R, Chandrakala S, Bargir UA, Madkaikar M. Targeted next-generation sequencing revealed a novel homozygous mutation in the LRBA gene causes severe hemolysis associated with inborn errors of immunity. Hematology. 2022;27:441–8.
doi: 10.1080/16078454.2022.2058736 pubmed: 35413226

Auteurs

Ayse Aygun (A)

Faculty of Medicine, Department of Pediatric Immunology, Ege University, 35100, Bornova, Izmir, Turkey.

Ezgi Topyıldız (E)

Faculty of Medicine, Department of Pediatric Immunology, Ege University, 35100, Bornova, Izmir, Turkey.

Mehmet Geyik (M)

Faculty of Medicine, Department of Pediatric Immunology, Ege University, 35100, Bornova, Izmir, Turkey.

Neslihan Edeer Karaca (NE)

Faculty of Medicine, Department of Pediatric Immunology, Ege University, 35100, Bornova, Izmir, Turkey.

Asude Durmaz (A)

Faculty of Medicine, Department of Medical Genetics, Ege University, Izmir, Turkey.

Guzide Aksu (G)

Faculty of Medicine, Department of Pediatric Immunology, Ege University, 35100, Bornova, Izmir, Turkey.

Ayca Aykut (A)

Faculty of Medicine, Department of Medical Genetics, Ege University, Izmir, Turkey.

Necil Kutukculer (N)

Faculty of Medicine, Department of Pediatric Immunology, Ege University, 35100, Bornova, Izmir, Turkey. necil.kutukculer@ege.edu.tr.

Classifications MeSH